Abstract
Hamza Abohamra, Keenau Mark Pearce
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2024
Isolation of a Human Prostate Carcinoma Cell Line (DU 145)
10.1002/ijc.2910210305 · 1978
Establishment and Characterization of a Human Prostatic Carcinoma Cell Line (PC‐3)
1979
LNCaP Model of Human Prostatic Carcinoma
1983
Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research
10.3390/cancers12092651 · 2020
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
10.1126/science.1117679 · 2005
Differential Expression of 5α‐reductase Isoenzymes in the Human Prostate and Prostatic Carcinomas
10.1002/(sici)1097-0045(199610)29:4<261::aid-pros7>3.0.co;2-e · 1996
Molecular Characterization of Human Prostate Carcinoma Cell Lines
10.1002/pros.10290 · 2003
Cell Lines Used in Prostate Cancer Research: A Compendium of Old and New Lines, Part 1
10.1097/01.ju.0000141580.30910.57 · 2005
Cell Lines Used in Prostate Cancer Research: A Compendium of Old and New Lines, Part 2
10.1097/01.ju.0000149989.01263.dc · 2005
In Vitro and In Vivo Model Systems Used in Prostate Cancer Research
10.14440/jbm.2015.63 · 2015
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient‐Derived Xenografts, and Three‐Dimensional Culture of Patient‐Derived Cells
10.3390/cells8010074 · 2019
Immortalized and Tumorigenic Adult Human Prostatic Epithelial Cell Lines: Characteristics and Applications Part I. Cell Markers and Immortalized Nontumorigenic Cell Lines
10.1002/(sici)1097-0045(199612)29:6<386::aid-pros7>3.0.co;2-6 · 1996
Immortalized and Tumorigenic Adult Human Prostatic Epithelial Cell Lines: Characteristics and Applications. Part 2. Tumorigenic Cell Lines
10.1002/(sici)1097-0045(19970101)30:1<58::aid-pros9>3.0.co;2-h · 1997
Organoid Cultures Derived From Patients With Advanced Prostate Cancer
10.1016/j.cell.2014.08.016 · 2014
Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures
10.1016/j.cell.2014.08.017 · 2014
Check Your Cultures! A List of Cross‐Contaminated or Misidentified Cell Lines
10.1002/ijc.25242 · 2010
Recombinant Origin of the Retrovirus XMRV
10.1126/science.1205292 · 2011
Molecular Characterization of TMPRSS2‐ERG Gene Fusion in the NCI‐H660 Prostate Cancer Cell Line: A New Perspective for an Old Model
10.1593/neo.07103 · 2007
Widely Used Prostate Carcinoma Cell Lines Share Common Origins
10.1002/pros.1045 · 2001
Immortalization of Human Adult Normal Prostatic Epithelial Cells by Liposomes Containing Large T‐SV40 Gene
10.1016/s0022-5347(17)37953-3 · 1991
Functional Expression of SV40 in Normal Human Prostatic Epithelial and Fibroblastic Cells: Differentiation Pattern of Nontumorigenic Cell Lines
1995
Human Prostatic Cell Line PNT1A, a Useful Tool for Studying Androgen Receptor Transcriptional Activity and Its Differential Subnuclear Localization in the Presence of Androgens and Antiandrogens
10.1016/s0303-7207(01)00669-4 · 2001
Androgen Responsive Adult Human Prostatic Epithelial Cell Lines Immortalized by Human Papillomavirus 18
10.1093/carcin/18.6.1215 · 1997
Stepwise Immortalization and Transformation of Adult Human Prostate Epithelial Cells by a Combination of HPV‐18 and v‐Ki‐ras
10.1073/pnas.91.25.11874 · 1994
Establishment and Characterization of an Immortalized but Non‐Transformed Human Prostate Epithelial Cell Line: BPH‐1
10.1007/bf02631333 · 1995
Characterization of Adult Human Prostatic Epithelial Cells Immortalized by Polybrene‐Induced DNA Transfection with a Plasmid Containing an Origin‐Defective SV40 Genome
1994
The Oncogenic Potential of a Prostate Cancer‐Derived Androgen Receptor Mutant
10.1002/pros.20544 · 2007
Establishment and Characterization of a Pair of Non‐Malignant and Malignant Tumor Derived Cell Lines from an African American Prostate Cancer Patient
2010
Proteomic Characterization of Paired Non‐Malignant and Malignant African‐American Prostate Epithelial Cell Lines Distinguishes Them by Structural Proteins
10.1186/s12885-017-3462-7 · 2017
Differential Cytokeratin Expression in Normal, Hyperplastic and Malignant Epithelial Cells from Human Prostate
10.1016/s0022-5347(17)39903-2 · 1990
A Human Prostatic Stromal Myofibroblast Cell Line WPMY‐1: A Model for Stromal‐Epithelial Interactions in Prostatic Neoplasia
10.1093/carcin/20.7.1185 · 1999
Leptin Mediates Prostate Stromal Cell Proliferation, Smooth Muscle Contraction, and Mitochondrial Function in Benign Prostate Hyperplasia
10.2147/dmso.s420258 · 2023
Effects of Androgen Receptor and Androgen on Gene Expression in Prostate Stromal Fibroblasts and Paracrine Signaling to Prostate Cancer Cells
10.1371/journal.pone.0016027 · 2011
PC3 Is a Cell Line Characteristic of Prostatic Small Cell Carcinoma
10.1002/pros.21383 · 2011
Characteristics of the Biphasic Action of Androgens and of the Potent Antiproliferative Effects of the New Pure Antiestrogen EM‐139 on Cell Cycle Kinetic Parameters in LNCaP Human Prostatic Cancer Cells
1991
A Mutation in the Ligand Binding Domain of the Androgen Receptor of Human INCaP Cells Affects Steroid Binding Characteristics and Response to Anti‐Androgens
10.1016/s0006-291x(05)80067-1 · 1990
Derivation of Androgen‐Independent Human LNCaP Prostatic Cancer Cell Sublines: Role of Bone Stromal Cells
10.1002/ijc.2910570319 · 1994
Androgen‐Independent Cancer Progression and Bone Metastasis in the LNCaP Model of Human Prostate Cancer
1994
VCaP, a Cell‐Based Model System of Human Prostate Cancer
2001
Genetics and Biology of Prostate Cancer
10.1101/gad.315739.118 · doi-reference
Enzalutamide Inhibits Testosterone‐Induced Growth of Human Prostate Cancer Xenografts in Zebrafish and Can Induce Bradycardia
10.1038/s41598-017-14413-w · doi-reference
The Lobund‐Wistar Rat Model of Prostate Cancer
10.1002/jcb.240501220 · doi-reference
Prostate Intraepithelial Neoplasia Induced by Prostate Restricted Akt Activation: The MPAKT Model
10.1073/pnas.1232229100 · doi-reference
Myc‐Driven Murine Prostate Cancer Shares Molecular Features With Human Prostate Tumors
10.1016/s1535-6108(03)00197-1 · doi-reference
SMAD4‐dependent Barrier Constrains Prostate Cancer Growth and Metastatic Progression
10.1038/nature09677 · doi-reference
Prostate‐Specific Deletion of the Murine Pten Tumor Suppressor Gene Leads to Metastatic Prostate Cancer
10.1016/s1535-6108(03)00215-0 · doi-reference
Dissociation of Epithelial and Neuroendocrine Carcinoma Lineages in the Transgenic Adenocarcinoma of Mouse Prostate Model of Prostate Cancer
10.2353/ajpath.2008.070602 · doi-reference
Organoid Culture Systems for Prostate Epithelial and Cancer Tissue
10.1038/nprot.2016.006 · doi-reference
Androgen‐Repressed Phenotype in Human Prostate Cancer
10.1073/pnas.93.26.15152 · doi-reference
Androgen Receptor Expression in Androgen‐Independent Prostate Cancer Cell Lines
10.1002/pros.1048 · doi-reference
DU‐145 and PC‐3 Human Prostate Cancer Cell Lines Express Androgen Receptor: Implications for the Androgen Receptor Functions and Regulation
10.1016/j.febslet.2006.03.041 · doi-reference
The DU145 Human Prostate Carcinoma Cell Line Harbors a Temperature‐Sensitive Allele of p53
10.1002/pros.20462 · doi-reference
p53 Oncogene Mutations in Three Human Prostate Cancer Cell Lines
10.1002/pros.2990230206 · doi-reference
Characterization of Fibroblast‐Free CWR‐R1ca Castration‐Recurrent Prostate Cancer Cell Line
10.1002/pros.23190 · doi-reference
Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen‐Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP Cells
10.1210/mend.11.4.9906 · doi-reference
Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor That Mediates Prostate Cancer Therapy Resistance
10.1158/0008-5472.can-08-0594 · doi-reference
Ligand‐Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone‐Refractory Prostate Cancer
10.1158/0008-5472.can-08-2764 · doi-reference
A New Human Prostate Carcinoma Cell Line, 22Rv1
10.1007/s11626-999-0115-4 · doi-reference
Inactivation of the Tumor Suppressor PTEN/MMAC1 in Advanced Human Prostate Cancer through Loss of Expression
10.1073/pnas.95.9.5246 · doi-reference
LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics
10.1002/pros.23313 · doi-reference
LuCaP 35: A New Model of Prostate Cancer Progression to Androgen Independence
10.1002/pros.10198 · doi-reference
Progression of Metastatic Human Prostate Cancer to Androgen Independence in Immunodeficient SCID Mice
10.1038/nm0497-402 · doi-reference